Cargando…
Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
The stagnation in drug development for schizophrenia highlights the need for better translation between basic and clinical research. Understanding the neurobiology of schizophrenia presents substantial challenges but a key feature continues to be the involvement of subcortical dopaminergic dysfuncti...
Autores principales: | Kesby, JP, Eyles, DW, McGrath, JJ, Scott, JG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802623/ https://www.ncbi.nlm.nih.gov/pubmed/29382821 http://dx.doi.org/10.1038/s41398-017-0071-9 |
Ejemplares similares
-
Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models
por: Conn, Kyna-Anne, et al.
Publicado: (2020) -
Increasing dopamine synthesis in nigrostriatal circuits increases phasic dopamine release and alters dorsal striatal connectivity: implications for schizophrenia
por: Srivastav, Sunil, et al.
Publicado: (2023) -
Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia
por: Kesby, James P., et al.
Publicado: (2013) -
Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology
por: Abbadessa, Gianmarco, et al.
Publicado: (2023) -
Pharmacy practice: Is the gap between the North and South widening?
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2012)